[EN] NOVEL PROCESS FOR MAKING (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIC ACID FORM A<br/>[FR] NOUVEAU PROCÉDÉ POUR PRÉPARER LA FORME A DE L'ACIDE (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIQUE
申请人:ASTRAZENECA AB
公开号:WO2009082344A1
公开(公告)日:2009-07-02
The present invention is directed to a novel process for the preparation of the crystalline form A of (2R)-(3-amino-2-fluoropropyl)phosphinic acid.
本发明涉及一种制备(2R)-(3-氨基-2-氟丙基)膦酸晶型A的新工艺。
[EN] NOVEL CRYSTALLINE FORM C OF (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIC ACID<br/>[FR] NOUVELLE FORME CRISTALLINE C DE L'ACIDE (2R)-(3-AMINO-2-FLUOROPROPYL) PHOSPHINIQUE
申请人:ASTRAZENECA AB
公开号:WO2009082348A1
公开(公告)日:2009-07-02
The present invention relates to a novel crystalline form of (2R)-(3-amino-2- fluoropropyl)phosphinic acid, the present invention is also directed to the use of the crystalline form for the treatment of gast rointestinal disorders as well as to a pharmaceutical composition comprising the same and a process for the preparation of the crystalline form.
[EN] NOVEL CRYSTALLINE FORM B OF (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIC ACID<br/>[FR] NOUVELLE FORME CRISTALLINE B DE L'ACIDE (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIQUE
申请人:ASTRAZENECA AB
公开号:WO2009082345A1
公开(公告)日:2009-07-02
The present invention relates to a novel crystalline form of (2R)-(3-amino-2- fluoropropyl)phosphinic acid, the present invention is also directed to the use of the crystalline form for the treatment of gastrointestinal disorders as well as to a pharmaceutical compositions comprising the same and a process for the preparation of the crystalline form.